Basic Information
| LncRNA/CircRNA Name | circPTPRA |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | qPCR |
| Sample | bladder cancer tissues |
| Expression Pattern | down-regulated |
| Function Description | we verified that circPTPRA is down-regulated in clinical BC specimens compared with the matched non-tumor samples, while correlation analyses showed that low circPTPRA expression is associated with poor prognosis, advanced tumor stage and larger tumor size. |
| Pubmed ID | 31821171 |
| Year | 2019 |
| Title | CircPTPRA acts as a tumor suppressor in bladder cancer by sponging miR-636 and upregulating KLF9 |
External Links
| Links for circPTPRA | GenBank HGNC NONCODE |
| Links for bladder cancer | OMIM COSMIC |